T. Rowe Price Group Inc. is planning to launch its first cryptocurrency fund, a bold move for the mutual-fund giant that mostly trades in traditional stocks and bonds. The actively managed ...

Those millions of dead people supposedly claiming Social Security? It’s obvious now that they were bogus. VIDEO: Federal government plan to kill nearly half a million barred owls Kelly Clarkson Looks ...

A "Trey Songz/Chris Brown type beat" produced by Dices. Contact information in description for purchase. Jeff Hoffman Gets Honest About Who He Blames For Jays' World Series Loss ICE arrested 361 ...

Pep Guardiola's side stayed unbeaten in the league phase with their victory at Estadio de la Ceramica, secured by first half goals from Haaland and then Bernardo Silva. Norwegian target man Haaland ...

LOS ANGELES (AP) — Luka Doncic had 29 points, 11 rebounds and 10 assists, Austin Reaves scored 26 points, and the Los Angeles Lakers beat the Miami Heat 130-120 on Sunday night to extend their winning ...

RIVERSIDE, Calif. -- Individuals who are physically fit may be better equipped to handle the negative effects of dehydration, according to research from the University of California, Riverside. In a ...

An international team from China and Australia has discovered a new vulnerability in prostate cancer cells – a previously unknown mechanism that scientists say could help combat one of the most common ...

A Jefferson County judge has dismissed charges against a 37-year-old man in a deadly 2021 shooting in Birmingham. Joshua Casey Wilson, of Odenville, was charged with manslaughter in the slaying of ...

"I can't die, I need to be here for my 10-year-old son, so we've got to sort this out." This was Caroline Palmer's first thought after hearing she had been diagnosed with primary central nervous ...

Celestica Inc. (NYSE:CLS) is one of the AI Stocks on the Market’s Radar. On October 29, BMO Capital raised the firm’s price target the stock to $370 from $300 and kept an Outperform rating on the ...

In the third quarter, lower sales of Biogen’s multiple sclerosis (“MS”) drugs are likely to have been offset by sequential revenue growth from new products. Sales of Biogen’s MS drugs like Tecfidera ...